Evidence suggests that these medications exert protective effects through multiple physiological pathways, including modest reductions in systolic blood pressure, improvements in lipid metabolism, attenuation of inflammatory signaling, delayed gastric emptying, and significant weight reduction
Yes, most prior authorization criteria for weight loss medications require documentation that the patient has actively participated in a comprehensive weight management program for 3-6 months without success
11 Future Perspectives 11.1 Monotherapy Given the modest weight loss delivered by SGLT2 inhibitors, it is not likely that they will be successful as monotherapies for obesity
And, given that the nature of this disease isnt fully understood, no definitive treatments exist yet
The FDA recommends mixing expired injectables with unpalatable substances (like coffee grounds), placing them in a sealed bag, and disposing of them in household waste
Visible body recomposition, meaning a clear shift in the ratio of fat to lean tissue, usually appears over 36 months of progressive training combined with adequate protein intake
